
Sign up to save your podcasts
Or


Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. The most recent edition, published this month, ranks each pharma based on their total revenues for 2023.
This week on "The Top Line," Fierce Pharma Senior Editor Eric Sagonowsky and Senior Writer Kevin Dunleavy break down the numbers, highlight key trends and share some of the biggest changes at the top and bottom of the rankings year over year.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
By Fierce Life Sciences4
1111 ratings
Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. The most recent edition, published this month, ranks each pharma based on their total revenues for 2023.
This week on "The Top Line," Fierce Pharma Senior Editor Eric Sagonowsky and Senior Writer Kevin Dunleavy break down the numbers, highlight key trends and share some of the biggest changes at the top and bottom of the rankings year over year.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.

30,844 Listeners

3,234 Listeners

963 Listeners

1,983 Listeners

1,657 Listeners

1,091 Listeners

335 Listeners

1,052 Listeners

228 Listeners

6,087 Listeners

35 Listeners

151 Listeners

21 Listeners

77 Listeners

141 Listeners